DTRA: regulatory initiative leaders
The Decentralized Trials and Research Alliance has named the co-leaders of its Initiative 4B: Collaborate on regulatory Gaps. Johnathan Andrus (CBO of Clinical Ink) and Chantal Le Floch (head of global regulatory affairs for the EU in general medicines for Sanofi) will facilitate and create workshops, organizing the team, and overseeing activities.
“We have an opportunity to craft a regulatory blueprint and establish a DCT regulatory framework that will benefit patients for years to come,” Andrus said. “I am honored to contribute to the evolutionary framework of both DCT technology and the clinical trials industry as a whole.”